NCT03531086View on ClinicalTrials.gov

Idiopathic Parkinson's Progression and Dopamine Transporter SPECT

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
Parkinson Disease
Interventions
DRUG

Ioflupane I 123

Ioflupane I 123 will be administered IV push prior to SPECT imaging

Trial Locations (1)

40536

University of Kentucky Department of Neurology, Lexington

All Listed Sponsors
lead

Julie Gurwell

OTHER

NCT03531086 - Idiopathic Parkinson's Progression and Dopamine Transporter SPECT | Biotech Hunter | Biotech Hunter